• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 21, 2022 at 10:52: AM
via Surge Therapeutics' hydrogel is engineered to deliver a cancer immunotherapy. Rather than replace surgery, CEO Michael Goldberg says the hydrogel could supplement this standard of care for solid tumors. The startup's Series A financing will support the technology's first test in humans.

article source
 




Top Bottom
Back
Quote